Pathway ID | hsa05200 |
Pathway Term | Pathways in cancer |
Pathway Source | KEGG |
Gene Symbol | Description | Entrez ID | Uniprot ID | Chromosomal Location |
---|---|---|---|---|
AKT3 |
v-akt murine thymoma viral oncogene homolog 3 |
10000 |
Q9Y243 |
chr1: 243,488,233-243,851,079 |
CDK2 |
cyclin-dependent kinase 2 |
1017 |
P24941 |
chr12: 55,966,769-55,972,784 |
CDK4 |
cyclin-dependent kinase 4 |
1019 |
P11802 |
chr12: 57,747,727-57,756,013 |
CDK6 |
cyclin-dependent kinase 6 |
1021 |
Q00534 |
chr7: 92,604,921-92,836,594 |
RASGRP2 |
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
10235 |
Q7LDG7 |
chr11: 64,726,911-64,745,456 |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
1026 |
P38936 |
chr6: 36,676,460-36,687,339 |
CDKN1B |
cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
1027 |
P46527 |
chr12: 12,715,058-12,722,371 |
CDKN2B |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
1030 |
P42772 |
chr9: 22,002,903-22,009,363 |
LAMC3 |
laminin subunit gamma 3 |
10319 |
Q9Y6N6 |
chr9: 131,009,082-131,094,473 |
TFG |
TRK-fused gene |
10342 |
Q92734 |
chr3: 100,709,331-100,748,966 |
ADCY3 |
adenylate cyclase 3 |
109 |
O60266 |
chr2: 24,819,169-24,919,839 |
RALBP1 |
ralA binding protein 1 |
10928 |
Q15311 |
chr18: 9,475,009-9,538,116 |
RASSF1 |
Ras association (RalGDS/AF-6) domain family member 1 |
11186 |
Q9NS23 |
chr3: 50,329,782-50,340,980 |
EGLN3 |
egl-9 family hypoxia-inducible factor 3 |
112399 |
Q9H6Z9 |
chr14: 33,924,231-34,462,774 |
ADCY7 |
adenylate cyclase 7 |
113 |
P51828 |
chr16: 50,246,137-50,318,135 |
ADCY9 |
adenylate cyclase 9 |
115 |
O60503 |
chr16: 3,953,387-4,116,185 |
CKS1B |
CDC28 protein kinase regulatory subunit 1B |
1163 |
P61024 |
chr1: 154,974,653-154,979,249 |
CKS2 |
CDC28 protein kinase regulatory subunit 2 |
1164 |
P33552 |
chr9: 89,311,198-89,316,703 |
COL4A2 |
collagen, type IV, alpha 2 |
1284 |
P08572 |
chr13: 110,305,812-110,513,027 |
COL4A3 |
collagen, type IV, alpha 3 (Goodpasture antigen) |
1285 |
Q01955 |
chr2: 227,164,565-227,314,792 |
COL4A6 |
collagen, type IV, alpha 6 |
1288 |
Q14031 |
chrX: 108,155,607-108,439,497 |
CREBBP |
CREB binding protein |
1387 |
Q92793 |
chr16: 3,725,054-3,880,726 |
CRKL |
v-crk avian sarcoma virus CT10 oncogene homolog-like |
1399 |
P46109 |
chr22: 20,917,426-20,953,749 |
CSF1R |
colony stimulating factor 1 receptor |
1436 |
P07333 |
chr5: 150,053,291-150,113,372 |
CSF3R |
colony stimulating factor 3 receptor |
1441 |
Q99062 |
chr1: 36,466,043-36,483,278 |
CTBP2 |
C-terminal binding protein 2 |
1488 |
P56545 |
chr10: 124,984,317-125,161,170 |
CTNNA1 |
catenin alpha 1 |
1495 |
P35221 |
chr5: 138,610,967-138,935,034 |
CTNNA2 |
catenin alpha 2 |
1496 |
P26232 |
chr2: 79,185,231-80,648,861 |
CTNNB1 |
catenin beta 1 |
1499 |
P35222 |
chr3: 41,194,837-41,260,096 |
DAPK1 |
death-associated protein kinase 1 |
1612 |
P53355 |
chr9: 87,497,228-87,708,633 |
DAPK3 |
death-associated protein kinase 3 |
1613 |
O43293 |
chr19: 3,958,453-3,971,123 |
AGTR1 |
angiotensin II receptor, type 1 |
185 |
P30556 |
chr3: 148,697,784-148,743,008 |
E2F1 |
E2F transcription factor 1 |
1869 |
Q01094 |
chr20: 33,675,683-33,686,404 |
E2F2 |
E2F transcription factor 2 |
1870 |
Q14209 |
chr1: 23,506,430-23,531,220 |
EDNRA |
endothelin receptor type A |
1909 |
P25101 |
chr4: 147,480,917-147,544,954 |
EGFR |
epidermal growth factor receptor |
1956 |
P00533 |
chr7: 55,019,021-55,211,628 |
EP300 |
E1A binding protein p300 |
2033 |
Q09472 |
chr22: 41,091,786-41,180,079 |
EPAS1 |
endothelial PAS domain protein 1 |
2034 |
Q99814 |
chr2: 46,293,667-46,386,703 |
ERBB2 |
erb-b2 receptor tyrosine kinase 2 |
2064 |
P04626 |
chr17: 39,687,914-39,730,426 |
AKT1 |
v-akt murine thymoma viral oncogene homolog 1 |
207 |
P31749 |
chr14: 104,769,349-104,795,751 |
AKT2 |
v-akt murine thymoma viral oncogene homolog 2 |
208 |
P31751 |
chr19: 40,230,317-40,285,536 |
ETS1 |
v-ets avian erythroblastosis virus E26 oncogene homolog 1 |
2113 |
P14921 |
chr11: 128,458,761-128,587,558 |
F2R |
coagulation factor II (thrombin) receptor |
2149 |
P25116 |
chr5: 76,716,043-76,735,781 |
FGF2 |
fibroblast growth factor 2 (basic) |
2247 |
P09038 |
chr4: 122,826,708-122,898,236 |
FGF7 |
fibroblast growth factor 7 |
2252 |
P21781 |
chr15: 49,423,096-49,488,775 |
FGF9 |
fibroblast growth factor 9 |
2254 |
P31371 |
chr13: 21,671,383-21,704,498 |
FGF11 |
fibroblast growth factor 11 |
2256 |
Q92914 |
chr17: 7,438,273-7,444,937 |
FGF12 |
fibroblast growth factor 12 |
2257 |
P61328 |
chr3: 192,139,395-192,767,764 |
FGF13 |
fibroblast growth factor 13 |
2258 |
Q92913 |
chrX: 138,614,731-139,222,777 |
FGF14 |
fibroblast growth factor 14 |
2259 |
Q92915 |
chr13: 101,710,804-102,402,457 |
FGFR1 |
fibroblast growth factor receptor 1 |
2260 |
P11362 |
chr8: 38,411,138-38,468,834 |
FGFR2 |
fibroblast growth factor receptor 2 |
2263 |
P21802 |
chr10: 121,478,334-121,598,458 |
FH |
fumarate hydratase |
2271 |
P07954 |
chr1: 241,497,603-241,519,761 |
FOXO1 |
forkhead box O1 |
2308 |
Q12778 |
chr13: 40,469,953-40,666,597 |
PLCB1 |
phospholipase C beta 1 |
23236 |
Q9NQ66 |
chr20: 8,077,251-8,968,360 |
FN1 |
fibronectin 1 |
2335 |
P02751 |
chr2: 215,360,440-215,436,172 |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
2353 |
P01100 |
chr14: 75,278,774-75,282,230 |
GLI2 |
GLI family zinc finger 2 |
2736 |
P10070 |
chr2: 120,735,623-120,992,653 |
GLI3 |
GLI family zinc finger 3 |
2737 |
P10071 |
chr7: 41,960,950-42,237,870 |
GNA11 |
guanine nucleotide binding protein (G protein), alpha 11 (Gq class) |
2767 |
P29992 |
chr19: 3,094,410-3,124,004 |
GNA12 |
guanine nucleotide binding protein (G protein) alpha 12 |
2768 |
Q03113 |
chr7: 2,728,112-2,844,324 |
GNAI1 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 |
2770 |
P63096 |
chr7: 80,133,955-80,219,402 |
GNAI2 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 |
2771 |
P04899 |
chr3: 50,226,292-50,259,355 |
GNAI3 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3 |
2773 |
P08754 |
chr1: 109,548,611-109,618,321 |
GNAQ |
guanine nucleotide binding protein (G protein), q polypeptide |
2776 |
P50148 |
chr9: 77,716,087-78,031,458 |
GNAS |
GNAS complex locus |
2778 |
O95467 |
chr20: 58,839,718-58,911,192 |
GNB1 |
guanine nucleotide binding protein (G protein), beta polypeptide 1 |
2782 |
P62873 |
chr1: 1,785,285-1,891,117 |
GNB2 |
guanine nucleotide binding protein (G protein), beta polypeptide 2 |
2783 |
P62879 |
chr7: 100,673,531-100,679,174 |
GNB3 |
guanine nucleotide binding protein (G protein), beta polypeptide 3 |
2784 |
P16520 |
chr12: 6,839,954-6,847,393 |
GNG4 |
guanine nucleotide binding protein (G protein), gamma 4 |
2786 |
P50150 |
chr1: 235,547,687-235,650,754 |
GNG5 |
guanine nucleotide binding protein (G protein), gamma 5 |
2787 |
P63218 |
chr1: 84,498,325-84,506,565 |
GNG7 |
guanine nucleotide binding protein (G protein), gamma 7 |
2788 |
O60262 |
chr19: 2,511,219-2,702,709 |
GNG11 |
guanine nucleotide binding protein (G protein), gamma 11 |
2791 |
P61952 |
chr7: 93,921,699-93,928,610 |
GRB2 |
growth factor receptor bound protein 2 |
2885 |
P62993 |
chr17: 75,318,076-75,405,709 |
GSK3B |
glycogen synthase kinase 3 beta |
2932 |
P49841 |
chr3: 119,821,323-120,094,417 |
GSTP1 |
glutathione S-transferase pi 1 |
2950 |
P09211 |
chr11: 67,583,595-67,586,660 |
MSH6 |
mutS homolog 6 |
2956 |
P52701 |
chr2: 47,695,530-47,810,101 |
HDAC1 |
histone deacetylase 1 |
3065 |
Q13547 |
chr1: 32,292,086-32,333,635 |
HDAC2 |
histone deacetylase 2 |
3066 |
Q92769 |
chr6: 113,933,028-114,011,308 |
HGF |
hepatocyte growth factor (hepapoietin A; scatter factor) |
3082 |
P14210 |
chr7: 81,699,006-81,770,438 |
HIF1A |
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
3091 |
Q16665 |
chr14: 61,695,513-61,748,259 |
APC |
adenomatous polyposis coli |
324 |
P25054 |
chr5: 112,707,498-112,846,239 |
BIRC3 |
baculoviral IAP repeat containing 3 |
330 |
Q13489 |
chr11: 102,317,450-102,339,403 |
XIAP |
X-linked inhibitor of apoptosis |
331 |
P98170 |
chrX: 123,859,724-123,913,979 |
BIRC5 |
baculoviral IAP repeat containing 5 |
332 |
O15392 |
chr17: 78,214,186-78,225,636 |
HSP90AA1 |
heat shock protein 90kDa alpha family class A member 1 |
3320 |
P07900 |
chr14: 102,080,738-102,139,699 |
HSP90AB1 |
heat shock protein 90kDa alpha family class B member 1 |
3326 |
P08238 |
chr6: 44,246,166-44,253,888 |
IGF1 |
insulin like growth factor 1 |
3479 |
P05019 |
chr12: 102,395,867-102,480,645 |
IGF1R |
insulin like growth factor 1 receptor |
3480 |
P08069 |
chr15: 98,648,971-98,964,530 |
KLK3 |
kallikrein related peptidase 3 |
354 |
P07288 |
chr19: 50,854,915-50,860,764 |
FAS |
Fas cell surface death receptor |
355 |
P25445 |
chr10: 88,990,582-89,015,785 |
IL6 |
interleukin 6 |
3569 |
P05231 |
chr7: 22,725,884-22,732,002 |
CXCL8 |
chemokine (C-X-C motif) ligand 8 |
3576 |
P10145 |
chr4: 73,740,506-73,743,716 |
ITGA6 |
integrin subunit alpha 6 |
3655 |
P23229 |
chr2: 172,427,354-172,506,282 |
AR |
androgen receptor |
367 |
P10275 |
chrX: 67,544,032-67,730,619 |
ITGA2 |
integrin subunit alpha 2 |
3673 |
P17301 |
chr5: 52,989,326-53,094,779 |
ITGA3 |
integrin subunit alpha 3 |
3675 |
P26006 |
chr17: 50,055,968-50,090,481 |
ITGAV |
integrin subunit alpha V |
3685 |
P06756 |
chr2: 186,590,065-186,680,901 |
ITGB1 |
integrin subunit beta 1 |
3688 |
P05556 |
chr10: 32,900,319-33,005,792 |
JAK1 |
Janus kinase 1 |
3716 |
P23458 |
chr1: 64,833,229-64,966,504 |
JUN |
jun proto-oncogene |
3725 |
P05412 |
chr1: 58,780,788-58,784,327 |
JUP |
junction plakoglobin |
3728 |
P14923 |
chr17: 41,754,604-41,786,931 |
KIT |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
3815 |
P10721 |
chr4: 54,657,918-54,740,715 |
KRAS |
Kirsten rat sarcoma viral oncogene homolog |
3845 |
P01116 |
chr12: 25,204,789-25,250,936 |
RHOA |
ras homolog family member A |
387 |
P61586 |
chr3: 49,359,145-49,412,998 |
LAMA2 |
laminin subunit alpha 2 |
3908 |
P24043 |
chr6: 128,883,141-129,516,569 |
LAMA3 |
laminin subunit alpha 3 |
3909 |
Q16787 |
chr18: 23,689,443-23,955,066 |
LAMA4 |
laminin subunit alpha 4 |
3910 |
Q16363 |
chr6: 112,108,760-112,254,939 |
LAMB1 |
laminin subunit beta 1 |
3912 |
P07942 |
chr7: 107,923,799-108,003,255 |
LAMC1 |
laminin subunit gamma 1 |
3915 |
P11047 |
chr1: 183,023,460-183,145,592 |
ARNT |
aryl hydrocarbon receptor nuclear translocator |
405 |
P27540 |
chr1: 150,809,705-150,876,768 |
SMAD2 |
SMAD family member 2 |
4087 |
Q15796 |
chr18: 47,808,957-47,931,146 |
SMAD3 |
SMAD family member 3 |
4088 |
P84022 |
chr15: 67,063,763-67,195,195 |
SMAD4 |
SMAD family member 4 |
4089 |
Q13485 |
chr18: 51,028,394-51,085,045 |
MDM2 |
MDM2 proto-oncogene, E3 ubiquitin protein ligase |
4193 |
Q00987 |
chr12: 68,808,176-68,850,686 |
MET |
MET proto-oncogene, receptor tyrosine kinase |
4233 |
P08581 |
chr7: 116,672,390-116,798,386 |
KITLG |
KIT ligand |
4254 |
P21583 |
chr12: 88,492,793-88,580,851 |
MITF |
microphthalmia-associated transcription factor |
4286 |
O75030 |
chr3: 69,739,435-69,968,337 |
MLH1 |
mutL homolog 1 |
4292 |
P40692 |
chr3: 36,993,332-37,050,918 |
MMP1 |
matrix metallopeptidase 1 |
4312 |
P03956 |
chr11: 102,789,920-102,798,160 |
MMP2 |
matrix metallopeptidase 2 |
4313 |
P08253 |
chr16: 55,389,700-55,506,691 |
MMP9 |
matrix metallopeptidase 9 |
4318 |
P14780 |
chr20: 46,008,908-46,016,561 |
MSH2 |
mutS homolog 2 |
4436 |
P43246 |
chr2: 47,402,969-47,562,311 |
MSH3 |
mutS homolog 3 |
4437 |
P20585 |
chr5: 80,654,648-80,876,460 |
MYC |
v-myc avian myelocytomatosis viral oncogene homolog |
4609 |
P01106 |
chr8: 127,735,434-127,741,434 |
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
4790 |
P19838 |
chr4: 102,501,329-102,617,302 |
NRAS |
neuroblastoma RAS viral (v-ras) oncogene homolog |
4893 |
P01111 |
chr1: 114,704,469-114,716,894 |
NTRK1 |
neurotrophic tyrosine kinase, receptor, type 1 |
4914 |
P04629 |
chr1: 156,815,640-156,881,850 |
PDGFA |
platelet-derived growth factor alpha polypeptide |
5154 |
P04085 |
chr7: 497,258-520,296 |
PDGFB |
platelet-derived growth factor beta polypeptide |
5155 |
P01127 |
chr22: 39,223,359-39,244,751 |
PDGFRA |
platelet-derived growth factor receptor, alpha polypeptide |
5156 |
P16234 |
chr4: 54,229,097-54,298,247 |
PDGFRB |
platelet-derived growth factor receptor, beta polypeptide |
5159 |
P09619 |
chr5: 150,113,837-150,155,872 |
SUFU |
suppressor of fused homolog (Drosophila) |
51684 |
Q9UMX1 |
chr10: 102,503,987-102,633,535 |
PGF |
placental growth factor |
5228 |
P49763 |
chr14: 74,941,834-74,955,784 |
PIK3CA |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
5290 |
P42336 |
chr3: 179,148,114-179,240,093 |
PIK3CB |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta |
5291 |
P42338 |
chr3: 138,652,699-138,834,938 |
PIK3CD |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta |
5293 |
O00329 |
chr1: 9,651,732-9,729,114 |
PIK3R1 |
phosphoinositide-3-kinase regulatory subunit 1 |
5295 |
P27986 |
chr5: 68,215,720-68,301,821 |
PLCG2 |
phospholipase C gamma 2 |
5336 |
P16885 |
chr16: 81,739,097-81,962,693 |
PLD1 |
phospholipase D1 |
5337 |
Q13393 |
chr3: 171,600,405-171,810,950 |
CYCS |
cytochrome c, somatic |
54205 |
P99999 |
chr7: 25,120,091-25,125,361 |
PPARD |
peroxisome proliferator-activated receptor delta |
5467 |
Q03181 |
chr6: 35,342,558-35,428,191 |
PPARG |
peroxisome proliferator-activated receptor gamma |
5468 |
P37231 |
chr3: 12,287,368-12,434,356 |
PRKACA |
protein kinase, cAMP-dependent, alpha catalytic subunit |
5566 |
P17612 |
chr19: 14,091,688-14,118,084 |
PRKCA |
protein kinase C, alpha |
5578 |
P17252 |
chr17: 66,302,636-66,810,743 |
PRKCB |
protein kinase C, beta |
5579 |
P05771 |
chr16: 23,836,001-24,220,611 |
MAPK1 |
mitogen-activated protein kinase 1 |
5594 |
P28482 |
chr22: 21,754,500-21,867,680 |
MAPK3 |
mitogen-activated protein kinase 3 |
5595 |
P27361 |
chr16: 30,114,105-30,123,506 |
MAPK8 |
mitogen-activated protein kinase 8 |
5599 |
P45983 |
chr10: 48,306,639-48,439,360 |
MAPK9 |
mitogen-activated protein kinase 9 |
5601 |
P45984 |
chr5: 180,233,143-180,292,099 |
MAP2K1 |
mitogen-activated protein kinase kinase 1 |
5604 |
Q02750 |
chr15: 66,386,817-66,492,312 |
MAP2K2 |
mitogen-activated protein kinase kinase 2 |
5605 |
P36507 |
chr19: 4,090,321-4,124,129 |
BAD |
BCL2 associated agonist of cell death |
572 |
Q92934 |
chr11: 64,269,830-64,284,704 |
PTCH1 |
patched 1 |
5727 |
Q13635 |
chr9: 95,442,980-95,517,057 |
PTEN |
phosphatase and tensin homolog |
5728 |
P60484 |
chr10: 87,863,113-87,971,930 |
PTGER2 |
prostaglandin E receptor 2 |
5732 |
P43116 |
chr14: 52,314,305-52,328,606 |
PTGER3 |
prostaglandin E receptor 3 |
5733 |
P43115 |
chr1: 70,852,353-71,047,808 |
PTGER4 |
prostaglandin E receptor 4 |
5734 |
P35408 |
chr5: 40,679,498-40,693,735 |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
5743 |
P35354 |
chr1: 186,671,791-186,680,427 |
PLEKHG5 |
pleckstrin homology and RhoGEF domain containing G5 |
57449 |
O94827 |
chr1: 6,466,092-6,520,061 |
PTK2 |
protein tyrosine kinase 2 |
5747 |
Q05397 |
chr8: 140,657,900-141,002,216 |
BAX |
BCL2-associated X protein |
581 |
Q07812 |
chr19: 48,954,815-48,961,798 |
RAC1 |
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) |
5879 |
P63000 |
chr7: 6,374,523-6,403,977 |
RAC2 |
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
5880 |
P15153 |
chr22: 37,225,261-37,244,448 |
RAC3 |
ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) |
5881 |
P60763 |
chr17: 82,031,624-82,034,204 |
RAD51 |
RAD51 recombinase |
5888 |
Q06609 |
chr15: 40,694,774-40,732,339 |
RAF1 |
Raf-1 proto-oncogene, serine/threonine kinase |
5894 |
P04049 |
chr3: 12,583,601-12,664,226 |
RALA |
v-ral simian leukemia viral oncogene homolog A (ras related) |
5898 |
P11233 |
chr7: 39,623,483-39,708,124 |
RALB |
v-ral simian leukemia viral oncogene homolog B |
5899 |
P11234 |
chr2: 120,240,064-120,294,713 |
RALGDS |
ral guanine nucleotide dissociation stimulator |
5900 |
Q12967 |
chr9: 133,097,720-133,149,334 |
RB1 |
retinoblastoma 1 |
5925 |
P06400 |
chr13: 48,303,751-48,481,986 |
BCL2 |
B-cell CLL/lymphoma 2 |
596 |
P10415 |
chr18: 63,123,346-63,320,128 |
RELA |
v-rel avian reticuloendotheliosis viral oncogene homolog A |
5970 |
Q04206 |
chr11: 65,653,596-65,663,094 |
BCR |
breakpoint cluster region |
613 |
P11274 |
chr22: 23,179,704-23,318,037 |
RXRB |
retinoid X receptor beta |
6257 |
P28702 |
chr6: 33,193,588-33,200,688 |
BID |
BH3 interacting domain death agonist |
637 |
P55957 |
chr22: 17,734,138-17,774,770 |
CXCL12 |
chemokine (C-X-C motif) ligand 12 |
6387 |
P48061 |
chr10: 44,370,165-44,386,493 |
HHIP |
hedgehog interacting protein |
64399 |
Q96QV1 |
chr4: 144,646,021-144,745,271 |
BMP2 |
bone morphogenetic protein 2 |
650 |
P12643 |
chr20: 6,767,664-6,780,280 |
SKP2 |
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase |
6502 |
Q13309 |
chr5: 36,151,989-36,184,319 |
SLC2A1 |
solute carrier family 2 (facilitated glucose transporter), member 1 |
6513 |
P11166 |
chr1: 42,925,375-42,959,173 |
BMP4 |
bone morphogenetic protein 4 |
652 |
P12644 |
chr14: 53,949,736-53,958,761 |
SOS1 |
SOS Ras/Rac guanine nucleotide exchange factor 1 |
6654 |
Q07889 |
chr2: 38,981,396-39,124,345 |
SOS2 |
SOS Ras/Rho guanine nucleotide exchange factor 2 |
6655 |
Q07890 |
chr14: 50,117,120-50,231,558 |
BRCA2 |
breast cancer 2 |
675 |
P51587 |
chr13: 32,315,474-32,400,266 |
STAT3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
6774 |
P40763 |
chr17: 42,313,324-42,388,568 |
STAT5A |
signal transducer and activator of transcription 5A |
6776 |
P42229 |
chr17: 42,287,547-42,311,943 |
STAT5B |
signal transducer and activator of transcription 5B |
6777 |
P51692 |
chr17: 42,199,168-42,276,707 |
STK4 |
serine/threonine kinase 4 |
6789 |
Q13043 |
chr20: 44,966,474-45,079,959 |
TCEB1 |
transcription elongation factor B (SIII), polypeptide 1 (15kDa, elongin C) |
6921 |
Q15369 |
chr8: 73,939,169-73,972,287 |
TCEB2 |
transcription elongation factor B (SIII), polypeptide 2 (18kDa, elongin B) |
6923 |
Q15370 |
chr16: 2,771,414-2,777,297 |
TCF7L2 |
transcription factor 7-like 2 (T-cell specific, HMG-box) |
6934 |
Q9NQB0 |
chr10: 112,950,250-113,167,678 |
TGFA |
transforming growth factor alpha |
7039 |
P01135 |
chr2: 70,447,280-70,554,193 |
TGFB1 |
transforming growth factor beta 1 |
7040 |
P01137 |
chr19: 41,301,587-41,353,911 |
TGFB2 |
transforming growth factor beta 2 |
7042 |
P61812 |
chr1: 218,346,235-218,444,619 |
TGFBR1 |
transforming growth factor beta receptor I |
7046 |
P36897 |
chr9: 99,104,038-99,154,192 |
TGFBR2 |
transforming growth factor beta receptor II |
7048 |
P37173 |
chr3: 30,606,502-30,694,142 |
TP53 |
tumor protein p53 |
7157 |
P04637 |
chr17: 7,661,779-7,687,550 |
TPM3 |
tropomyosin 3 |
7170 |
P06753 |
chr1: 154,155,304-154,194,648 |
TPR |
translocated promoter region, nuclear basket protein |
7175 |
P12270 |
chr1: 186,311,652-186,375,693 |
HSP90B1 |
heat shock protein 90kDa beta family member 1 |
7184 |
P14625 |
chr12: 103,930,107-103,953,645 |
TRAF1 |
TNF receptor associated factor 1 |
7185 |
Q13077 |
chr9: 120,902,393-120,929,173 |
VEGFA |
vascular endothelial growth factor A |
7422 |
P15692 |
chr6: 43,770,184-43,786,487 |
VEGFB |
vascular endothelial growth factor B |
7423 |
P49765 |
chr11: 64,234,538-64,238,793 |
VEGFC |
vascular endothelial growth factor C |
7424 |
P49767 |
chr4: 176,683,538-176,792,727 |
WNT2 |
wingless-type MMTV integration site family member 2 |
7472 |
P09544 |
chr7: 117,276,631-117,323,289 |
WNT3 |
wingless-type MMTV integration site family member 3 |
7473 |
P56703 |
chr17: 46,762,506-46,833,154 |
WNT5A |
wingless-type MMTV integration site family member 5A |
7474 |
P41221 |
chr3: 55,465,715-55,490,539 |
WNT6 |
wingless-type MMTV integration site family member 6 |
7475 |
Q9Y6F9 |
chr2: 218,859,821-218,874,233 |
WNT2B |
wingless-type MMTV integration site family member 2B |
7482 |
Q93097 |
chr1: 112,466,541-112,530,165 |
ZBTB16 |
zinc finger and BTB domain containing 16 |
7704 |
Q05516 |
chr11: 114,059,593-114,250,676 |
PAX8 |
paired box 8 |
7849 |
Q06710 |
chr2: 113,215,997-113,278,950 |
CXCR4 |
chemokine (C-X-C motif) receptor 4 |
7852 |
P61073 |
chr2: 136,114,349-136,118,165 |
CCDC6 |
coiled-coil domain containing 6 |
8030 |
Q16204 |
chr10: 59,788,763-59,906,656 |
NCOA4 |
nuclear receptor coactivator 4 |
8031 |
Q13772 |
chr10: 46,005,088-46,030,714 |
WNT5B |
wingless-type MMTV integration site family member 5B |
81029 |
Q9H1J7 |
chr12: 1,529,891-1,647,243 |
AXIN1 |
axin 1 |
8312 |
O15169 |
chr16: 287,440-352,673 |
FZD4 |
frizzled class receptor 4 |
8322 |
Q9ULV1 |
chr11: 86,945,679-86,955,391 |
FZD6 |
frizzled class receptor 6 |
8323 |
O60353 |
chr8: 103,298,433-103,332,866 |
FZD7 |
frizzled class receptor 7 |
8324 |
O75084 |
chr2: 202,034,587-202,038,445 |
FZD8 |
frizzled class receptor 8 |
8325 |
Q9H461 |
chr10: 35,638,249-35,642,278 |
TCF7L1 |
transcription factor 7-like 1 (T-cell specific, HMG-box) |
83439 |
Q9HCS4 |
chr2: 85,133,410-85,310,388 |
RASSF5 |
Ras association (RalGDS/AF-6) domain family member 5 |
83593 |
Q8WWW0 |
chr1: 206,507,530-206,589,448 |
CASP8 |
caspase 8 |
841 |
Q14790 |
chr2: 201,233,443-201,287,711 |
CASP9 |
caspase 9 |
842 |
P55211 |
chr1: 15,490,832-15,526,534 |
CUL2 |
cullin 2 |
8453 |
Q13617 |
chr10: 35,008,551-35,090,642 |
RUNX1 |
runt-related transcription factor 1 |
861 |
Q01196 |
chr21: 34,787,801-36,004,667 |
CBLB |
Cbl proto-oncogene B, E3 ubiquitin protein ligase |
868 |
Q13191 |
chr3: 105,655,461-105,869,552 |
FADD |
Fas associated via death domain |
8772 |
Q13158 |
chr11: 70,203,163-70,207,390 |
FGF18 |
fibroblast growth factor 18 |
8817 |
O76093 |
chr5: 171,419,656-171,457,623 |
CCNA1 |
cyclin A1 |
8900 |
P78396 |
chr13: 36,431,520-36,442,882 |
CCNE2 |
cyclin E2 |
9134 |
O96020 |
chr8: 94,879,770-94,896,678 |
ROCK2 |
Rho-associated, coiled-coil containing protein kinase 2 |
9475 |
O75116 |
chr2: 11,179,761-11,348,330 |
FGF19 |
fibroblast growth factor 19 |
9965 |
O95750 |
chr11: 69,698,232-69,704,642 |
RBX1 |
ring-box 1, E3 ubiquitin protein ligase |
9978 |
P62877 |
chr22: 40,951,347-40,973,309 |
CDC42 |
cell division cycle 42 |
998 |
P60953 |
chr1: 22,052,627-22,092,946 |